Literature DB >> 15616062

Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening.

Hiroko Iwakiri1, Noboru Nishihara, Osamu Nagata, Takashi Matsukawa, Makoto Ozaki, Daniel I Sessler.   

Abstract

Reported effect-site concentrations of propofol at loss of consciousness and recovery of consciousness vary widely. Thus, no single concentration based on a population average will prove optimal for individual patients. We therefore tested the hypothesis that individual propofol effect-site concentrations at loss and return of consciousness are similar. Propofol effect-site concentrations at loss and recovery of consciousness were estimated with a target-control infusion system in 20 adults. Propofol effect-site concentrations were gradually increased until the volunteers lost consciousness (no response to verbal stimuli); unconsciousness was maintained for 15 min, and the volunteers were then awakened. This protocol was repeated three times in each volunteer. Our major outcomes were the concentration producing unconsciousness and the relationship between the estimated effect-site concentrations at loss and recovery of consciousness. The target effect-site propofol concentration was 2.0 +/- 0.9 at loss of consciousness and 1.8 +/- 0.7 at return of consciousness (P <0.001). The average difference between individual effect-site concentrations at return and loss of consciousness was only 0.17 +/- 0.32 microg/mL (95% confidence interval for the difference 0.09-0.25 microg/mL). Our results thus suggest that individual titration to loss of consciousness is an alternative to dosing propofol on the basis of average population requirements.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616062      PMCID: PMC1343509          DOI: 10.1213/01.ANE.0000139358.15909.EA

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   6.627


  24 in total

1.  Effect-site modelling of propofol using auditory evoked potentials.

Authors:  M White; M J Schenkels; F H Engbers; A Vletter; A G Burm; J G Bovill; G N Kenny
Journal:  Br J Anaesth       Date:  1999-03       Impact factor: 9.166

2.  Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets.

Authors:  J F Coetzee; J B Glen; C A Wium; L Boshoff
Journal:  Anesthesiology       Date:  1995-06       Impact factor: 7.892

3.  Automated responsiveness test (ART) predicts loss of consciousness and adverse physiologic responses during propofol conscious sedation.

Authors:  A G Doufas; M Bakhshandeh; A R Bjorksten; R Greif; D I Sessler
Journal:  Anesthesiology       Date:  2001-04       Impact factor: 7.892

4.  The determinants of propofol induction of anesthesia dose.

Authors:  Y U Adachi; K Watanabe; H Higuchi; T Satoh
Journal:  Anesth Analg       Date:  2001-03       Impact factor: 5.108

5.  Pharmacodynamics of propofol in female patients.

Authors:  J Vuyk; F H Engbers; H J Lemmens; A G Burm; A A Vletter; M P Gladines; J G Bovill
Journal:  Anesthesiology       Date:  1992-07       Impact factor: 7.892

6.  Comparison of plasma compartment versus two methods for effect compartment--controlled target-controlled infusion for propofol.

Authors:  M M Struys; T De Smet; B Depoorter; L F Versichelen; E P Mortier; F J Dumortier; S L Shafer; G Rolly
Journal:  Anesthesiology       Date:  2000-02       Impact factor: 7.892

7.  Relation between initial blood distribution volume and propofol induction dose requirement.

Authors:  T Kazama; K Ikeda; K Morita; T Ikeda; M Kikura; S Sato
Journal:  Anesthesiology       Date:  2001-02       Impact factor: 7.892

8.  Relationship between bispectral index, auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points.

Authors:  S E Milne; A Troy; M G Irwin; G N C Kenny
Journal:  Br J Anaesth       Date:  2003-02       Impact factor: 9.166

9.  The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis.

Authors:  Ken B Johnson; Talmage D Egan; Steven E Kern; Julia L White; Scott W McJames; Noah Syroid; Derek Whiddon; Ty Church
Journal:  Anesthesiology       Date:  2003-08       Impact factor: 7.892

10.  Effect-site concentration of propofol for recovery of consciousness is virtually independent of fentanyl effect-site concentration.

Authors:  Hiroko Iwakiri; Osamu Nagata; Takashi Matsukawa; Makoto Ozaki; Daniel I Sessler
Journal:  Anesth Analg       Date:  2003-06       Impact factor: 5.108

View more
  26 in total

1.  Required decrement time to predict time of awaking in effect-site concentration can be estimated by using that in predicted blood concentration displayed on the commercial TCI pump.

Authors:  Takayuki Kunisawa; Yoshiko Onodera; Atsushi Kurosawa; Tomoki Sasakawa; Satoshi Hanada; Hiroshi Iwasaki
Journal:  J Anesth       Date:  2010-10-10       Impact factor: 2.078

Review 2.  SEDASYS(®), airway, oxygenation, and ventilation: anticipating and managing the challenges.

Authors:  Basavana Gouda Goudra; Preet Mohinder Singh; Vinay Chandrasekhara
Journal:  Dig Dis Sci       Date:  2014-01-08       Impact factor: 3.199

Review 3.  Propofol: a review of its role in pediatric anesthesia and sedation.

Authors:  Vidya Chidambaran; Andrew Costandi; Ajay D'Mello
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

4.  Changes of blood endocannabinoids during anaesthesia: a special case for fatty acid amide hydrolase inhibition by propofol?

Authors:  Carina Jarzimski; Matthias Karst; Alexander A Zoerner; Christin Rakers; Marcus May; Maria T Suchy; Dimitrios Tsikas; Joachim K Krauss; Dirk Scheinichen; Jens Jordan; Stefan Engeli
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

5.  Target-controlled infusion of propofol for a patient with myotonic dystrophy.

Authors:  Yasuhiro Morimoto; Masako Mii; Takao Hirata; Hiroaki Matayoshi; Takefumi Sakabe
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

Review 6.  State of the clinical science of perioperative brain health: report from the American Society of Anesthesiologists Brain Health Initiative Summit 2018.

Authors:  Elizabeth Mahanna-Gabrielli; Katie J Schenning; Lars I Eriksson; Jeffrey N Browndyke; Clinton B Wright; Deborah J Culley; Lis Evered; David A Scott; Nae Yah Wang; Charles H Brown; Esther Oh; Patrick Purdon; Sharon Inouye; Miles Berger; Robert A Whittington; Catherine C Price; Stacie Deiner
Journal:  Br J Anaesth       Date:  2019-08-19       Impact factor: 9.166

7.  A pharmacodynamic analysis of factors affecting recovery from anesthesia with propofol-remifentanil target controlled infusion.

Authors:  Bon-Nyeo Koo; Jeong-Rim Lee; Gyu-Jeong Noh; Jae-Hoon Lee; Young-Ran Kang; Dong-Woo Han
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

8.  In reply.

Authors:  Patrick L Purdon; David W Zhou; Oluwaseun Akeju; Emery N Brown
Journal:  Anesthesiology       Date:  2015-09       Impact factor: 7.892

9.  Anesthesia-induced loss of consciousness disrupts auditory responses beyond primary cortex.

Authors:  Aaron J Krom; Amit Marmelshtein; Hagar Gelbard-Sagiv; Ariel Tankus; Hanna Hayat; Daniel Hayat; Idit Matot; Ido Strauss; Firas Fahoum; Martin Soehle; Jan Boström; Florian Mormann; Itzhak Fried; Yuval Nir
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-12       Impact factor: 11.205

10.  Cortical functional connectivity indexes arousal state during sleep and anesthesia.

Authors:  Matthew I Banks; Bryan M Krause; Christopher M Endemann; Declan I Campbell; Christopher K Kovach; Mark Eric Dyken; Hiroto Kawasaki; Kirill V Nourski
Journal:  Neuroimage       Date:  2020-02-08       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.